Monopar Therapeutics
MNPR
$0.62
Share price
2.24%
Change (1 day)
-28.20%
Change (1 year)
Categories
Monopar Therapeutics (MNPR) Fails to deliver data
Key failure to deliver metrics for Monopar Therapeutics:
- Last SEC data release: 2024-04-30
- Last 15 days FTD volume: $0.03 M
- Last 3 months FTD volume: $4.12 M
- Last year FTD volume: $6.52 M
Failures to deliver for Monopar Therapeutics (MNPR) - 3 months history
Number of shares, 3 months chartBiweekly Failures to deliver volume for Monopar Therapeutics (MNPR) - since 2019
Volume in USD (price x number of shares), data since 2019Monopar Therapeutics (MNPR) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2024 | $4.15 M | 24.12% |
| 2023 | $3.34 M | 1752.7% |
| 2022 | $0.18 M | -97.03% |
| 2021 | $6.07 M | 6.3% |
| 2020 | $5.71 M | -23.53% |
| 2019 | $7.47 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3months) | FTD volume (1 year) | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $2.05 M | $6.99 M | 🇺🇸 USA |